Польща -
польська -
Ministerstwo Rolnictwa i Rozwoju Wsi
vorona 500 sc
adama agricultural solutions uk ltd. third floor east 1410 arlington business park, rg7 4sa berkshire, wielka brytania - folpet - 500 g - fungicyd
Польща -
польська -
Ministerstwo Rolnictwa i Rozwoju Wsi
samiron
arysta lifescience benelux sprl rue de renory, b-4102 ougre (seraing), królestwo belgii - chlorowodorek propamokarbu - 400 g, cymoksanil - 50 g - fungicyd
Польща -
польська -
Ministerstwo Rolnictwa i Rozwoju Wsi
evolution
arysta lifescience s.a.s. francja route d'artix, 64150 nogueres, francja - chizalofop-p etylu - 70 g, kletodym - 140 g - chwastobójczy
Польща -
польська -
Ministerstwo Rolnictwa i Rozwoju Wsi
passivo
sharda cropchem españa s.l carril condomina, 30006 murcja - difenokonazol - 250 g, paklobutrazol - 125 g - fungicyd
Польща -
польська -
Ministerstwo Rolnictwa i Rozwoju Wsi
rocky
sharda cropchem españa s.l carril condomina, 30006 murcja - difenokonazol - 250 g, paklobutrazol - 125 g - fungicyd
Греція -
грецька -
Εθνικός Οργανισμός Φαρμάκων
serenade aso
bayer ag - Συμπυκνωμένο αιώρημα (sc) - bacillus amyloliquefaciens ( former subtilis ) qst 713 96,69% β/ο (1 x 109 σπόρια/κ.εκ. σκευάσματος) Βοηθητικές ουσίες: 3,31% β/β
США -
англійська -
NLM (National Library of Medicine)
allergenic extract
antigen laboratories, inc. - chaetomium globosum (unii: 5016wb8b8a) (chaetomium globosum - unii:5016wb8b8a) - chaetomium globosum 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.
США -
англійська -
NLM (National Library of Medicine)
allergenic extract
nelco laboratories, inc. - aspergillus fumigatus (unii: x88df51t48) (aspergillus fumigatus - unii:x88df51t48) - aspergillus fumigatus 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t